Congress Blog How the US can harness the possibilities of biotechnology Congress Blog / 9 months ago by Carrie Wolinetz, opinion contributor 09/21/22 6:00 PM ET
Healthcare It’s no longer a luxury to treat rare diseases — we must act accordingly Healthcare / 2 years ago by Marshall Summar, opinion contributor 12/02/21 12:01 PM ET
International Why a Canada-China trade dispute was (almost) a gift to US biotech International / 2 years ago by Marc L. Busch, Opinion Contributor 10/01/21 11:00 AM ET
Health Care Stephen Hahn joining venture capital firm behind Moderna Health Care / 2 years ago by Celine Castronuovo 06/15/21 10:30 AM ET
Technology The good, the bad and the truly horrifying potential of CRISPR technology Technology / 2 years ago by David S. D'Amato, Opinion Contributor 04/23/21 3:30 PM ET
Healthcare Modern biomedical breakthroughs require a federal ethics commission Healthcare / 2 years ago by Kirstin R.W. Matthews and Ana S. Iltis, opinion contributors 04/16/21 12:01 PM ET
Healthcare For a faster end to COVID, waive intellectual property rights for its vaccines Healthcare / 2 years ago by Vanessa Kerry and Parsa Erfani, opinion contributors 03/19/21 11:01 AM ET
Technology How a DNA database can reunite migrant families Technology / 2 years ago by Sara H. Katsanis, Michael J. Stebbins, Jennifer K. Wagner, opinion contributors 02/11/21 3:30 PM ET
Energy and Environment Soon we’ll be able to engineer the wild, can the policies keep up with the science? Energy and Environment / 3 years ago by Michael Montague and Amanda Kobokovich, opinion contributors 06/29/20 4:30 PM ET
Healthcare Public quality standards for biologic drugs promote transparency and competition — don’t get rid of them Healthcare / 4 years ago by Liam Sigaud, opinion contributor 07/23/19 2:00 PM ET
Healthcare ‘Big Pharma’ is the big winner of the USMCA Healthcare / 4 years ago by Veronika J. Wirtz, Warren A. Kaplan and Kevin Gallagher 06/23/19 9:00 AM ET
International US must stand up for life-sciences innovation provisions in the USMCA International / 4 years ago by Stephen Ezell, Richard C. Owens, and Alberto Saracho, opinion contributors 06/06/19 1:30 PM ET
Healthcare We can keep synthetic biology miracles coming by investing in US research Healthcare / 5 years ago by Gigi Gronvall, opinion contributor 09/10/18 5:30 PM ET
Healthcare With some adjustments, America’s patent system can reclaim its gold standard status Healthcare / 5 years ago by Former Rep. James C. Greenwood (R-Pa.), opinion contributor 06/21/18 7:00 AM ET
Healthcare Industry shenanigans limit availability of affordable drugs Healthcare / 5 years ago by Peter J. Pitts, opinion contributor 05/11/18 12:15 PM ET
Healthcare Tide is finally turning for patient access to US biosimilars Healthcare / 5 years ago by Sheila Frame, opinion contributor 12/10/17 3:30 PM ET
